{"id":"NCT00329901","sponsor":"Novartis Vaccines","briefTitle":"Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years","officialTitle":"A Phase 3, Multi-Center, Observer Blind, Controlled, Randomized Study to Compare the Immunogenicity and Safety of the Concomitant Administration of a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis (Tdap) Vaccine and Chiron (Now Novartis) Meningococcal ACWY Conjugate Vaccine, With Either One Dose of Acellular Pertussis (Tdap) Vaccine, or One Dose of Chiron (Now Novartis) Meningococcal ACWY Conjugate Vaccine, in Healthy Subjects Aged 11-25 Years","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04","primaryCompletion":"2007-05","completion":"2007-12","firstPosted":"2006-05-25","resultsPosted":"2014-06-18","lastUpdate":"2014-06-18"},"enrollment":1072,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Disease","Meningococcal Meningitis"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal ACWY conjugate vaccine (MenACWY-CRM)","otherNames":[]},{"type":"BIOLOGICAL","name":"Combined tetanus, reduced diphtheria and acellular pertussis vaccine (Tdap)","otherNames":[]},{"type":"BIOLOGICAL","name":"saline placebo","otherNames":[]}],"arms":[{"label":"Tdap + MenACWY-CRM","type":"EXPERIMENTAL"},{"label":"Tdap + saline","type":"EXPERIMENTAL"},{"label":"MenACWY-CRM + saline","type":"EXPERIMENTAL"}],"summary":"Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years","primaryOutcome":{"measure":"Percentage of Subjects With an Immune Response Against Diphtheria, Tetanus and Pertussis, When Tdap is Concomitantly Administered With MenACWY-CRM Compared to Tdap Given Concomitantly With Saline Placebo","timeFrame":"1 month after vaccination (Day 29)","effectByArm":[{"arm":"Tdap+MenACWY-CRM","deltaMin":4,"sd":null},{"arm":"Tdap+Saline","deltaMin":5,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"11 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":14,"countries":["Italy"]},"refs":{"pmids":["20164251"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":359},"commonTop":["Injection site pain","Headache","Injection site induration","Myalgia","Injection site erythema"]}}